Abstract
This patient-centered case vignette offers insight into how best to choose among additional oral agents, basal insulin, or the newer GLP-1 receptor agonists.
MeSH terms
-
Diabetes Mellitus, Type 2* / diagnosis
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glycated Hemoglobin / analysis
-
Humans
-
Hypoglycemic Agents* / classification
-
Hypoglycemic Agents* / pharmacology
-
Medication Therapy Management
-
Metformin / pharmacology*
-
Practice Guidelines as Topic
Substances
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
Metformin